• Recursion Pharmaceuticals (NASDAQ:RXRX) Receives "Buy" Rating from Needham & Company LLC

    Источник: Buzz FX / 11 дек 2024 08:57:10   America/Chicago


    Recursion Pharmaceuticals (NASDAQ:RXRX) Receives "Buy" Rating from Needham & Company LLC Written by MarketBeat December 11, 2024 Share Link copied to clipboard. Recursion Pharmaceuticals ( NASDAQ:RXRX - Get Free Report ) 's stock had its "b
    Read more...
Опубликовать